VH segment usage in adult B-lineage acute lymphoblastic leukemia
. | No. patients with clones . | No. clones in VH families . | Total no. clones . | |||||
---|---|---|---|---|---|---|---|---|
VH1/VH7 . | VH2 . | VH3 . | VH4 . | VH5 . | VH6 . | |||
Adult B-lineage ALL | 127 | 50 | 13 | 88 | 46 | 7 | 41 | 245 |
(%) | (20.4) | (5.3) | (36.0) | (18.8) | (2.9) | (16.7) | ||
Subtypes | ||||||||
Null ALL | 12 | 4 | 0 | 4 | 6 | 2 | 4 | 20 |
(%) | (20) | (0) | (20) | (30) | (10) | (20) | ||
Common ALL | 68 | 33 | 5 | 53 | 23 | 3 | 18 | 135 |
(%) | (24.4) | (3.7) | (39.3) | (17) | (2.2) | (13.3) | ||
Pre-B ALL | 43 | 12 | 7 | 28 | 15 | 2 | 18 | 82 |
(%) | (14.6) | (8.5) | (34.1) | (18.3) | (2.4) | (22) | ||
B ALL | 4 | 1 | 1 | 3 | 2 | 0 | 1 | 8 |
(%) | (12.5) | (12.5) | (37.5) | (25) | (0) | (12.5) |
. | No. patients with clones . | No. clones in VH families . | Total no. clones . | |||||
---|---|---|---|---|---|---|---|---|
VH1/VH7 . | VH2 . | VH3 . | VH4 . | VH5 . | VH6 . | |||
Adult B-lineage ALL | 127 | 50 | 13 | 88 | 46 | 7 | 41 | 245 |
(%) | (20.4) | (5.3) | (36.0) | (18.8) | (2.9) | (16.7) | ||
Subtypes | ||||||||
Null ALL | 12 | 4 | 0 | 4 | 6 | 2 | 4 | 20 |
(%) | (20) | (0) | (20) | (30) | (10) | (20) | ||
Common ALL | 68 | 33 | 5 | 53 | 23 | 3 | 18 | 135 |
(%) | (24.4) | (3.7) | (39.3) | (17) | (2.2) | (13.3) | ||
Pre-B ALL | 43 | 12 | 7 | 28 | 15 | 2 | 18 | 82 |
(%) | (14.6) | (8.5) | (34.1) | (18.3) | (2.4) | (22) | ||
B ALL | 4 | 1 | 1 | 3 | 2 | 0 | 1 | 8 |
(%) | (12.5) | (12.5) | (37.5) | (25) | (0) | (12.5) |
ALL indicates acute lymphoblastic leukemia.